Lucis is a European preventive health platform that uses blood biomarker analysis and AI to deliver personalised, science-based health recommendations. The platform analyses more than 110 blood biomarkers and provides an AI-powered health companion app with personalised guidance reviewed by physicians.
Investment Rounds
Capital activity and funding progression
Industries
Frequently Asked Questions
Where is Lucis located?
Lucis is located in Paris, France.
What industries does Lucis operate in?
Lucis operates in the following industries: healthtech, artificial intelligence, preventive health.
When was Lucis founded?
Lucis was founded on 2026-05-26.
How much total funding has Lucis raised?
Lucis has raised a total of $28,500,000.
Who are the investors in Lucis?
The investors in Lucis are: Y Combinator, Kima Ventures, Motier Ventures, Circle.Co, North South Ventures, Singular, General Catalyst, Céline Lazorthes, Manu Lecomte.
Who are the founders of Lucis?
The founders of Lucis are: Maxime Berthelot.
What is the mission of Lucis?
The mission of Lucis is to transform health data into simple, actionable steps to help individuals optimize their long-term health and well-being through advanced biomarker analysis.
What kind of company is Lucis?
Lucis is a preventive health tech startup based in Paris that uses medical expertise and artificial intelligence to provide personalized health insights, biological age tracking, and science-based recommendations.
What should I expect when applying for a career at Lucis?
Candidates interested in a career at Lucis should expect to join a mission-driven team focused on preventive care and data-driven health, supported by backing from organizations like Y Combinator.